在克洛扎诱导心肌炎后重新使用克洛扎:一个案例报告来验证先前发布的协议
Sara J Russell1, Matthew Josdal2, Annabelle Wanson3
1PharmD Student, University of Saskatchewan College of Pharmacy and Nutrition, Saskatoon, Saskatchewan.
The mental health clinician
|October 13, 2025
概括
这份病例报告详细介绍了一名患有治疗耐药精神分裂症的患者的克洛扎宾重试成功的情况,并有克洛扎宾诱导的心肌炎的病史. 谨慎的协议允许有效治疗,而不会导致心肌炎复发.
科学领域:
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 克洛扎平对治疗耐药精神分裂症 (TRS) 具有至关重要的作用.
- 克洛扎诱导心肌炎 (CIM) 是一种严重的不良影响,限制了其使用.
- 暂停使用克洛沙平,对TRS的替代品很少,因此重新提出挑战是值得考虑的.
研究的目的:
- 报告一个成功的 clozapine 重试在一个有 CIM 的病史的病人.
- 评估克洛扎谨慎定位协议的安全性和有效性.
- 为了解TRS患者中CIM的管理做出贡献.
主要方法:
- 一名28岁的男性有CIM病史,接受了克洛扎再试.
- 采用了一个谨慎的定位协议,根据现有文献进行了调整.
- 同时使用苏克洛芬提克索尔和监测不良反应是管理的一部分.
主要成果:
- 患者成功地达到每日150毫克的克洛扎宾剂量.
- 在重新挑战期间没有观察到CIM的复发.
- 尽管有细胞炎等混因素,但重新挑战是成功的.
结论:
- 这一案例证实了使用谨慎的克洛扎再试剂方案的有效性.
- 它支持考虑在某些患有CIM的患者中重新使用克洛札.
- 需要进一步的研究来建立标准化的协议并评估长期结果.
相关概念视频
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...


